Fact CheckerSign in

NCT07903571Not yet recruiting

Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young

A Prospective Translational Tissue Collection Study in Gastrointestinal Cancers in Young Adults.

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

This study aims to better understand how gastrointestinal (digestive system) cancers develop and how they respond to treatment in young adults, in order to improve ways to prevent, diagnose, and manage these cancers in this age group.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
2 Jan 2026
Start date
1 Nov 2026
Primary completion date
1 Nov 2031
Lead sponsor
Royal Marsden NHS Foundation Trust
NCT number
NCT07903571

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 1 Nov 2026 to the primary completion date, 1 Nov 2031
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have received prior treatment for their gastrointestinal malignancy (includes any systemic anti-cancer therapy, radiotherapy and / or surgical resection.

Other illness

  • Patients with a cancer of pancreatic origin (existing institutional biobank), or hepatocellular carcinoma (HCC)
  • Patients with a history another of malignancy with within 2 years, excluding resected non melanomatous skin cancers.
    • \-

Who the study is looking for

  • -Cohort A: Colorectal Cancer including at least 20 patients with appendiceal cancer.
    • Cohort B: Gastro-oesophageal cancer
    • Cohort C: Hepato-biliary cancer
  • Patient is 18-50 years of age 3 Patient can understand the patient information sheet and is able to provide written informed consent.
    • 4\. Patient being treated at the Royal Marsden Hospital.

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.